Consequently, the TGF-β/Smad signaling pathway plays a critical role in the pathogenesis of pulmonary fibrosis and serves as a key therapeutic target for antifibrotic drugs (Du et al., 2024; Tirunavalli and Andugulapati, 2024; Wang et al., 2024). Here, TGFB1 is linked to pulmonary fibrosis.